Achilles therapeutics to present at the 41st annual j.p. morgan healthcare conference

London, dec. 20, 2022 (globe newswire) -- achilles therapeutics plc (nasdaq: achl), a clinical-stage biopharmaceutical company developing ai-powered precision t cell therapies to treat solid tumors, today announced that dr. iraj ali, chief executive officer, will present at the 41st annual j.p. morgan healthcare conference on thursday, january 12, 2023, at 8:15 am pst. the event will be held at the westin st. francis hotel in san francisco, california.
ACHL Ratings Summary
ACHL Quant Ranking